Trinity Biotech plc
TRIB · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $4 | $5 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $11 | $15 | $21 |
| Inventory | $20 | $20 | $19 | $22 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $33 | $36 | $41 | $46 |
| Property Plant & Equip (Net) | $4 | $4 | $5 | $4 |
| Goodwill | $0 | $0 | $14 | $0 |
| Intangibles | $56 | $54 | $38 | $47 |
| Long-Term Investments | $3 | $3 | $2 | $0 |
| Tax Assets | $4 | $4 | $4 | $1 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $67 | $64 | $62 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $100 | $100 | $103 | $97 |
| Liabilities | – | – | – | – |
| Payables | $26 | $25 | $7 | $25 |
| Short-Term Debt | $3 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $3 | $0 |
| Total Curr. Liab. | $32 | $30 | $32 | $28 |
| LT Debt | $100 | $95 | $88 | $82 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $5 | $5 | $5 | $2 |
| Other NC Liab. | $3 | $3 | $4 | $2 |
| Total NC Liab. | $118 | $113 | $106 | $96 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $13 | $12 |
| Total Liabilities | $149 | $143 | $138 | $124 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $2 |
| Retained Earnings | -$94 | -$88 | -$79 | -$62 |
| AOCI | $1 | $1 | -$5 | -$6 |
| Other Equity | $0 | $0 | $7 | $7 |
| Total Equity | -$50 | -$44 | -$35 | -$26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $100 | $100 | $103 | $97 |
| Net Debt | $100 | $94 | $83 | $79 |